Rossana Casaretti

990 total citations
44 papers, 657 citations indexed

About

Rossana Casaretti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Rossana Casaretti has authored 44 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 8 papers in Hepatology. Recurrent topics in Rossana Casaretti's work include Colorectal Cancer Treatments and Studies (34 papers), Gastric Cancer Management and Outcomes (20 papers) and Cancer Treatment and Pharmacology (15 papers). Rossana Casaretti is often cited by papers focused on Colorectal Cancer Treatments and Studies (34 papers), Gastric Cancer Management and Outcomes (20 papers) and Cancer Treatment and Pharmacology (15 papers). Rossana Casaretti collaborates with scholars based in Italy, United Kingdom and United States. Rossana Casaretti's co-authors include Antonio Avallone, G. Comella, Pasquale Comella, Salvatore Tafuto, P. Comella, Guglielmo Nasti, Alessandro Ottaiano, Anna Nappi, Carmela Romano and Lucrezia Silvestro and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Rossana Casaretti

43 papers receiving 633 citations

Peers

Countries citing papers authored by Rossana Casaretti

Since Specialization

Citations

This map shows the geographic impact of Rossana Casaretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rossana Casaretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rossana Casaretti more than expected).

Fields of papers citing papers by Rossana Casaretti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rossana Casaretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rossana Casaretti. The network helps show where Rossana Casaretti may publish in the future.

Co-authorship network of co-authors of Rossana Casaretti

This figure shows the co-authorship network connecting the top 25 collaborators of Rossana Casaretti. A scholar is included among the top collaborators of Rossana Casaretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rossana Casaretti. Rossana Casaretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II randomized study of maintenance therapy with regorafenib (REGO) versus placebo after first-line platinum and fluoropyrimidines-based chemotherapy in HER2 negative locally advanced/metastatic gastric (GC) or gastroesophageal junction (GEJ) cancer: Results of a-MANTRA study (GOIRC-05-2016). 2024 ·Journal of Clinical Oncology ·Angela Damato, Domenico Bilancia, Francesco Iachetta, Antonia Strippoli, (unknown), Rossana Casaretti, Ilaria Bernardini, (unknown), Giovanni Luca Frassineti, Francesca Di Fabio, Michele Aieta, Michele Ghidini, Chiara Trentin, Giovanni Gerardo Cardellino, Erika Gervasi, (unknown), Saverio Cinieri, Nicola Normanno, Carmine Pinto	1
2	1753P Universal DPYD genotyping in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy 2023 ·Annals of Oncology ·(unknown), Sergio Facchini, Francesca Collina, (unknown), Aurora Daniele, Rossana Casaretti, Antonino Cassata, Alfonso De Stefano, Anna Nappi, (unknown), Lucrezia Silvestro, Carmela Romano, N. Zanaletti, Fabiana Tatangelo, Stefano de Franciscis, (unknown), Francesco Izzo, Gerardo Ferrara, Paolo Delrio, Antonio Avallone	1
3	Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report 2023 ·Frontiers in Oncology ·Alfonso De Stefano, N. Zanaletti, Antonino Cassata, Lucrezia Silvestro, Anna Nappi, Rossana Casaretti, Carmela Romano, (unknown), Claudia Cardone, (unknown), Antonella Petrillo, Alfredo Budillon, Paolo Delrio, Antonio Avallone	1
4	Role of shrinkage in esophageal–gastric junction cancer 2023 ·SHILAP Revista de lepidopterología ·Maddalena Leongito, Raffaéle Palaia, Rossana Casaretti, Fabiana Tatangelo, (unknown), Annabella Di Mauro, Andrea Belli, Vittorio Albino	1
5	A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial 2022 ·Gastric Cancer ·Gerardo Rosati, Chiara Alessandra Cella, Luigi Cavanna, Carla Codecà, Michele Prisciandaro, Stefania Mosconi, Giovanna Luchena, Nicola Silvestris, Ilaria Bernardini, Rossana Casaretti, Federica Zoratto, D. Amoroso, A. Ciarlo, Sandro Barni, Stefano Cascinu, Cristina Davite, (unknown), (unknown), Domenico Bilancia, Roberto Labianca	4
6	First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis 2018 ·Frontiers in Pharmacology ·Alessandro Ottaiano, Alfonso De Stefano, Monica Capozzi, Anna Nappi, Chiara De Divitiis, Carmela Romano, Lucrezia Silvestro, Antonino Cassata, Rossana Casaretti, Salvatore Tafuto, Michele Caraglia, Massimiliano Berretta, Guglielmo Nasti, Antonio Avallone	9
7	Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives 2017 ·Current Cancer Drug Targets ·Anna Nappi, Massimiliano Berretta, Carmela Romano, Salvatore Tafuto, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Chiara De Divitiis, Lara Alessandrini, Francesco Fiorica, Alessandro Ottaiano, Guglielmo Nasti	53
8	Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy 2016 ·Cancer Immunology Research ·Anna Maria Trotta, Alessandro Ottaiano, Carmela Romano, Guglielmo Nasti, Anna Nappi, Chiara De Divitiis, Maria Napolitano, Serena Zanotta, Rossana Casaretti, Crescenzo D’Alterio, Antonio Avallone, Daniela Califano, Rosario Vincenzo Iaffaioli, Stefania Scala	62
9	Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome 2012 ·European Journal of Nuclear Medicine and Molecular Imaging ·Antonio Avallone, Luigi Aloj, Corradina Caracò, Paolo Delrio, Biagio Pecori, Fabiana Tatangelo, Nigel Scott, Rossana Casaretti, Francesca Di Gennaro, Massimo Montano, Lucrezia Silvestro, Alfredo Budillon, Secondo Lastoria	45
10	Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet 2010 ·Acta Oncologica ·Pasquale Comella, Rossana Casaretti, (unknown), Claudia Sandomenico, (unknown), Antonio Avallone, (unknown), (unknown)	10
11	Capecitabine, Alone and in Combination, in the Management of Patients with Colorectal Cancer 2008 ·Drugs ·Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, Antonio Avallone, (unknown)	15
12	Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinoma 2005 ·Cancer ·Pasquale Comella, D. Natale, A. Farris, Antonio Gambardella, Luigi Maiorino, B. Massidda, Rossana Casaretti, Salvatore Tafuto, Vito Lorusso, Silvana Leo, Michele Cannone	69
13	Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study 2005 ·Cancer Chemotherapy and Pharmacology ·P. Comella, B. Massidda, S. Palmeri, A. Farris, Lucia Liguori, D. Natale, Luigi Maiorino, Salvatore Tafuto, (unknown), Rossana Casaretti	8
14	Oxaliplatin plus irinotecan and leucovorin-modulated5-fluorouracil triplet regimen every other week:a dose-finding study in patients with advanced gastrointestinal malignancies 2002 ·Annals of Oncology ·P. Comella, Rossana Casaretti, Vincenzo De Rosa, Antonio Avallone, Francesco Izzo, Francesco Fiore, (unknown), G. Comella	20
15	Irinotecan and Mitomycin C in 5-Fluorouracil-Refractory Colorectal Cancer Patients 2001 ·Oncology ·(unknown), Maria Biglietto, Rossana Casaretti, (unknown), Antonio Avallone, Luigi Maiorino, Liberato Di Lullo, Giuseppe De Cataldis, (unknown), Giuseppe Comella	7
16	A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer 2001 ·British Journal of Cancer ·Stefano Cascinu, Francesco Graziano, Sandro Barni, Roberto Labianca, G. Comella, Rossana Casaretti, L. Frontini, Vincenzo Catalano, Anna Maria Baldelli, Giuseppina Catalano	40
17	Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study 1998 ·Breast Cancer Research and Treatment ·G. Frasci, Pasquale Comella, Giuseppe D’Aiuto, Alfredo Budillon, (unknown), Renato Thomas, Immacolata Capasso, Rossana Casaretti, Antonio Daponte, Francesco Caponigro, Adriano Gravina, Luigi Maiorino, (unknown), (unknown), Giuseppe Comella	23
18	Fotemustine and dacarbazine plus recombinant interferon alpha2a in the treatment of advanced melanoma 1997 ·European Journal of Cancer ·P. Comella, Antonio Daponte, Rossana Casaretti, Franco Ionna, Francesco Fiore, (unknown), G. Frasci, Francesco Caponigro, Adriano Gravina, (unknown), Nicola Mozzillo, G. Comella	10
19	Significance of Methotrexate Serum Level Achieved in Patients with Gastrointestinal Malignancies Treated with Sequential Methotrexate, <i>L</i>-Folinic Acid and 5-Fluorouracil 1996 ·Oncology ·Pasquale Comella, Giuseppe Palmieri, Gerardo Beneduce, Rossana Casaretti, Antonio Daponte, Adriano Gravina, G. Frasci, Edoardo Biondi, Giuseppe Comella	4
20	Combination of Vinorelbine, Cisplatin, and Etoposide in Advanced Non-Small Cell Lung Carcinoma: A Pilot Study 1994 ·Journal of Chemotherapy ·P. Comella, Rossana Casaretti, A. Daponte, (unknown), (unknown), Giuseppe Palmieri, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact